Friday, May 08, 2015 11:11:27 AM
Evaluating current assets;
Awaiting Northern Vine’s re-branded websites to go live;
Expecting Biocell to bring products to the direct sales market;
Working through the research and development (R&D) at Biocube
following a successful growth trial run;
Holding a future pipeline of product opportunities in IJuana;
and
Assessing the use of the Phytalab business model for deployment
into Northern Vine.
http://www.marijuanastocksreport.com/abattis-bioceuticals-investor-update-for-q2-2015/
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM